Registrations are now open for our 2024 Symposium - Innovations: Improving health outcomes for people who use methamphetamine and emerging drugs. Register here: https://lnkd.in/g7vCbHiC
National Centre for Clinical Research on Emerging Drugs (NCCRED)
Research Services
Randwick, New South Wales 191 followers
Clinicians, researchers and community working together to provide evidence based public health for people who use drugs
About us
We are an innovative centre bringing together clinicians and researchers to detect and respond to trends in emerging drug health. NCCRED strives to forge world-leading excellence in the treatment of methamphetamine and other emerging drugs of concern. We never lose sight of the fact that people who use drugs, as well as their families, carers and communities are at the core of what we do. NCCRED aims to collaborate and build the capacity and scope for new clinical research into emerging drugs; and rapidly translate these findings into best clinical practice. Funded by the Commonwealth Department of Health, NCCRED is made up of a consortium: - The National Centre for Education and Training on Addiction (NCETA, Flinders University) - The National Drug Research Institute (NDRI, Curtin University) - The National Drug and Alcohol Research Centre (NDARC, The University of New South Wales) - St Vincent’s Health Australia. We are governed by a Board with an independent Chair.
- Website
-
https://nccred.org.au/
External link for National Centre for Clinical Research on Emerging Drugs (NCCRED)
- Industry
- Research Services
- Company size
- 11-50 employees
- Headquarters
- Randwick, New South Wales
- Type
- Educational
- Specialties
- Clinical Research
Locations
-
Primary
22-32 King St
Randwick, New South Wales 2031, AU
Employees at National Centre for Clinical Research on Emerging Drugs (NCCRED)
-
Nadine Ezard
Director at National Centre for Clinical Research in Emerging Drugs (NCCRED), Clinical Director St Vincent's Hospital Sydney Alcohol & Drug Servicec
-
Ed Broadbent
Public Health Director & Project Manager | Social Entrepreneur | Founder
-
Kathryn Fletcher
Senior Research Associate at NCCRED | Clinical Psychologist
-
Andrea Delgado
Executive Assistant at National Centre for Clinical Research on Emerging Drugs (NCCRED)
Updates
-
Register for our next webinar: GHB insights for service providers This webinar will cover what GHB is and why people use it, as well as recent learnings from research, including: 🔹 changing demographics in GHB use 🔹 harm reduction learnings 🔹 withdrawal management Sign up: https://lnkd.in/gkPCDWPd
Welcome! You are invited to join a webinar: NCCRED Webinar - GHB Insights for Service Providers. After registering, you will receive a confirmation email about joining the webinar.
us06web.zoom.us
-
Our most recent webinar explores the role of family and friends in treatments for methamphetamine use, including the latest evidence base and suggestions for how the AOD can better support family and friends. You can watch the recording and see relevant resources here: https://lnkd.in/gupVdBxe
Methamphetamine webinar: working with family & friends
https://nccred.org.au
-
Our Director Nadine Ezard contributed to last week's coverage on the ABC about increasing harms from nitazenes in Australia. Nitazenes are a group of highly potent synthetic opioids, up to 1000 times more potent than morphine by some measures, and have been found in Australia in several substances, including heroin, MDMA and cocaine. Watch the report: https://lnkd.in/gjgAqJf8
Fears of more overdoses as nitazenes infiltrate Australia's underground drug supply | 7.30
https://www.youtube.com/
-
We are recruiting for a Clinical Project Manager! This role will manage a multi-centre randomised controlled clinical trial, and is responsible for developing trial procedures, designing study collateral and the implementation of the study across at least 6 sites. Find out more and apply:
Clinical Project Manager - NCCRED
external-careers.jobs.unsw.edu.au
-
Please share with your contacts or let us know if you know anywhere or anyone who may be interested in knowing more about this trial!
Researchers at St Vincent’s Hospital Sydney and UNSW are looking for people over the age of 18 who use methamphetamine to be involved in a clinical trial with a new medication. The NABU study will be trialling an oral naltrexone-bupropion combination medication for methamphetamine use disorder. To express interest in the study please follow the link: https://lnkd.in/gmiTJqKA For further information regarding the trial please contact: Email: [email protected] Phone: 0436 613 342 NABU Pilot Recruitment Social Media Text Version 1.0 dated 08 April 2024
-
-
Researchers at St Vincent’s Hospital Sydney and UNSW are looking for people over the age of 18 who use methamphetamine to be involved in a clinical trial with a new medication. The NABU study will be trialling an oral naltrexone-bupropion combination medication for methamphetamine use disorder. To express interest in the study please follow the link: https://lnkd.in/gmiTJqKA For further information regarding the trial please contact: Email: [email protected] Phone: 0436 613 342 NABU Pilot Recruitment Social Media Text Version 1.0 dated 08 April 2024
-
-
Join us for a webinar next month about working with the families and friends of people who use methamphetamine, featuring a presentation from Clare Rushton (University of Wollongong and NSW Health.) Sign up: https://lnkd.in/gZu3YuJQ
Webinar - Methamphetamine: working with families and friends
us06web.zoom.us
-
There is growing evidence of harms due to nitazenes in Australia. Nitazenes are a group of highly potent synthetic opioids, up to 1000 times more potent than morphine by some measures. Our new briefing covers the origins of nitazenes, their presence and impact in Australia, and an overview of harm reduction strategies to respond to them: https://lnkd.in/gudnk97G
Emerging drug briefings
https://nccred.org.au
-
We are hosting a webinar next week about Australian preparedness for nitazenes, a group of highly potent synthetic opioids. We will be joined by two colleagues from Ireland, who will be discussing a cluster of overdoses that occurred in Ireland last year after an influx of nitazenes on the market. Sign up: https://lnkd.in/eZX7nsZU
NCCRED Webinars
https://nccred.org.au